SCHEMBL7816362

SCHEMBL7816362

Cc1nc2c(s1)C(=O)c1ccccc1C2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.55
TDO2 P48775 1/20 0.55
CDK4 P11802 7/20 0.50
PTGS1 P23219 2/20 0.44
PTGS2 P35354 2/20 0.44
MAPT P10636 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.44
NPC1 O15118 1/20 0.44
AHR P35869 1/20 0.44
KMT5A Q9NQR1 2/20 0.43
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
CCND1 P24385 1/20 0.43
BLM P54132 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9071199 0.93 IDO1 (0.47) IDO1TDO2CDK4PTGS1PTGS2
SCHEMBL16885422 0.87 CDK4 (0.46) IDO1TDO2CDK4PTGS1PTGS2
SCHEMBL13470368 0.80 CDK4 (0.45) CDK4PTGS1PTGS2KMT5AMEN1
SCHEMBL7818266 0.78 IDO1 (0.55) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL1287137 0.78 IDO1 (0.55) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL10719313 0.77 IDO1 (0.51) IDO1TDO2PTGS2MAPTRAB9A
SCHEMBL10220599 0.77 IDO1 (0.51) IDO1TDO2MAPTRAB9ASMN1; SMN2
SCHEMBL13470064 0.75 CDK4 (0.45) CDK4PTGS1PTGS2KMT5AMEN1
SCHEMBL12973032 0.75 CDK4 (0.45) CDK4PTGS1PTGS2KMT5AMEN1
SCHEMBL7808047 0.75 IDO1 (0.79) IDO1TDO2PTGS2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725425-B1 Compounds and methods for treating cancer DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-08-08 US disclosed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 US disclosed